(Q48431455)

11 February 2018

title

In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles. (English)

1 reference

11 February 2018

1 reference

Adrian Newman-Tancredi

4

1 reference

11 February 2018

author name string

Marie-Bernadette Assié

1

1 reference

11 February 2018

Hélène Dominguez

2

1 reference

11 February 2018

Nathalie Consul-Denjean

3

1 reference

11 February 2018

publication date

1 September 2006

1 reference

11 February 2018

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

11 February 2018

volume

373

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

441-450

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00210-006-0092-z

exact match

0 references

cites work

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity

1 reference

https://api.crossref.org/works/10.1007%2FS00210-006-0092-Z

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-006-0092-Z

In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-006-0092-Z

Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-006-0092-Z

Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-006-0092-Z

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-006-0092-Z

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase

21 January 2018

1 reference

12 December 2020

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.

1 reference

12 December 2020

Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms.

1 reference

12 December 2020

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Adrenergic receptors as models for G protein-coupled receptors

1 reference

12 December 2020

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties

1 reference

12 December 2020

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

1 reference

12 December 2020

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

1 reference

12 December 2020

Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine

1 reference

12 December 2020

Characterization of [3H]nemonapride binding to mouse brain dopamine D2 receptors assessed in vivo and ex vivo for metabolic modeling in PET studies

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

1 reference

12 December 2020

DU-127090 Solvay/H Lundbeck

1 reference

12 December 2020

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

1 reference

12 December 2020

Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models

1 reference

12 December 2020

Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

1 reference

12 December 2020

Buspirone in the treatment of tardive dyskinesia.

1 reference

12 December 2020

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

1 reference

12 December 2020

Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist

1 reference

12 December 2020

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

1 reference

12 December 2020

The third dopamine receptor (D3) as a novel target for antipsychotics

1 reference

12 December 2020

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

12 December 2020

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

12 December 2020

The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties

1 reference

12 December 2020

Half a century of antipsychotics and still a central role for dopamine D2 receptors

1 reference

12 December 2020

Mechanism of new antipsychotic medications: occupancy is not just antagonism

1 reference

12 December 2020

Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.

1 reference

12 December 2020

Clozapine occupies high levels of dopamine D2 receptors

1 reference

12 December 2020

Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia.

1 reference

12 December 2020

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

1 reference

12 December 2020

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

1 reference

12 December 2020

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

1 reference

12 December 2020

Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats

1 reference

12 December 2020

Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride

1 reference

12 December 2020

Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor

1 reference

12 December 2020

Atypical antipsychotic induced mild hypothermia

1 reference

12 December 2020

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

12 December 2020

Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride

1 reference

12 December 2020

Is there a role for 5-HT1A agonists in the treatment of depression?

1 reference

12 December 2020

Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy

1 reference

12 December 2020

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

12 December 2020

Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo

1 reference

12 December 2020

Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex

1 reference

12 December 2020

Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.

1 reference

12 December 2020

Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients

1 reference

12 December 2020

Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies

1 reference

12 December 2020

SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.

1 reference

12 December 2020

10.1007/S00210-006-0092-Z

Identifiers

DOI

1 reference

11 February 2018

release_45c5j7twkrdxflvy752fwxx3ti

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/45c5j7twkrdxflvy752fwxx3ti

24 November 2022

mapped directly with Wikidata item

PubMed ID

16947046

1 reference

11 February 2018